Shares of Ceapro Inc. (CVE:CZO – Get Free Report) traded up 8.3% during trading on Friday . The stock traded as high as C$0.26 and last traded at C$0.26. 72,000 shares were traded during trading, an increase of 43% from the average session volume of 50,465 shares. The stock had previously closed at C$0.24.
Ceapro Stock Performance
The firm has a market cap of C$20.36 million, a price-to-earnings ratio of -8.67 and a beta of 1.39. The company has a current ratio of 11.00, a quick ratio of 18.88 and a debt-to-equity ratio of 7.82. The stock’s 50 day moving average is C$0.23 and its 200 day moving average is C$0.24.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Further Reading
- Five stocks we like better than Ceapro
- What Does Downgrade Mean in Investing?
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Calculate Inflation Rate
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Election Stocks: How Elections Affect the Stock Market
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
